Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centres

Journal of Surgical Oncology

Volumn 107, Issue 4, 2013, Pages 312-319

  Kusamura, Shigeki ^a   Baratti, Dario ^a   Virzì, Salvatore ^b   Bonomi, Serena ^b   Iusco, Domenico Rosario ^b   Grassi, Antonio ^b   Hutanu, Ionut ^c   Deraco, Marcello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Ospedale di Bentivoglio   (Italy)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; learning curve; peritoneal surface malignancies; peritonectomy

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; ITALY; LEARNING CURVE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIOPERATIVE PERIOD; PERITONEUM CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FELLOWSHIPS AND SCHOLARSHIPS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; ITALY; LEARNING CURVE; LOGISTIC MODELS; MALE; MENTORS; MIDDLE AGED; NEOPLASM, RESIDUAL; ODDS RATIO; PERITONEAL NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84874256323     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23231     Document Type: Article

References (34)

1. Elias D, Gilly F, Quenet F, et al.: Association Française de Chirurgie. Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010; 36: 456-462.
2. Yan TD, Deraco M, Baratti D, et al.: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: Multi-institutional experience. J Clin Oncol 2009; 27: 6237-6242.
3. Cao C, Yan TD, Black D, et al.: A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Review. Ann Surg Oncol 2009; 16: 2152-2165.
4. Yan TD, Black D, Sugarbaker PH, et al.: A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Review. Ann Surg Oncol 2007; 14: 2702-2713.
5. Deraco M, Baratti D, Laterza B, et al.: Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. Review. Eur J Surg Oncol 2011; 37: 4-9.
6. Yan TD, Links M, Fransi S, et al.: Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-A journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 2007; 14: 2270-2280.
7. Cavaliere F, Valle M, De Rosa B, et al.: Peritonectomy and chemohyperthermia in the treatment of peritoneal carcinomatosis: Learning curve. Suppl Tumori 2005; 4: S119-S121.
8. Smeenk RM, Verwaal VJ, Zoetmulder FA,: Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 2007; 94: 1408-1414.
9. Mohamed F, Moran BJ,: Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: The importance of a learning curve. Review. Cancer J 2009; 15: 196-199.
10. Matheny ME, Ohno-Machado L, Resnic FS,: Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology. Am Heart J 2008; 155: 114-120.
11. Chen TT, Chung KP, Hu FC, et al.: The use of statistical process control (risk-adjusted CUSUM, risk-adjusted RSPRT and CRAM with prediction limits) for monitoring the outcomes of out-of-hospital cardiac arrest patients rescued by the EMS system. J Eval Clin Pract 2011; 17: 71-77.
12. Grigg OA, Farewell VT, Spiegelhalter DJ,: Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res 2003; 12: 147-170.
13. Steiner SH, Cook RJ, Farewell VT,: Risk-adjusted monitoring of binary surgical outcomes. Med Decis Making 2001; 21: 163-169.
14. Rogers CA, Reeves BC, Caputo M, et al.: Control chart methods for monitoring cardiac surgical performance and their interpretation. J Thorac Cardiovasc Surg 2004; 28: 811-819.
15. Kusamura S, Baratti D, Deraco M,: Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg 2012; 255: 348-356.
16. Cook JA, Ramsay CR, Fayers P,: Statistical evaluation of learning curve effects in surgical trials. Clin Trials 2004; 1: 421-427.
17. Baratti D, Scivales A, Balestra MR, et al.: Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic ntraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 2010; 36: 463-469.
18. Sugarbaker PH,: Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43: S15-S25.
19. Bozzetti F, Yu W, Baratti D, et al.: Locoregional treatment of peritoneal carcinomatosis from gastric cancer. Review. J Surg Oncol 2008; 98: 273-276.
20. Deraco M, Baratti D, Kusamura S, et al.: Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol 2009; 100: 321-328.
21. Jacquet P, Sugarbaker PH,: Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996; 15: 49-58.
22. Baratti D, Kusamura S, Nonaka D, et al.: Pseudomyxoma peritonei: Clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008; 15: 526-534.
23. Rossi CR, Foletto M, Mocellin S, et al.: Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: Phase I study. Cancer 2002; 94: 492-499.
24. González-Moreno S, Sugarbaker PH,: Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004; 91: 304-311.
25. Yan TD, Yoo D, Sugarbaker PH,: Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 2006; 32: 948-953.
26. Kusamura S, Baratti D, Younan R, et al.: Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 2007; 14: 2550-2558.
27. Younan R, Kusamura S, Baratti D, et al.: Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005; 12: 910-918.
28. Charlson ME, Pompei P, Ales KL, et al.: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
29. Lemeshow S, Hosmer DW, Jr:, A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982; 115: 92-106.
30. Chua T, Yan TD, Saxena A, et al.: Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg 2009; 249: 900-907.
31. Glehen O, Gilly FN, Boutitie F, et al., French Surgical Association: Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: A multi-institutional study of 1,290 patients. Cancer 2010; 116: 5608-5618.
32. Youssef H, Newman C, Chandrakumaran K, et al.: Operative findings, early complications, and long-term survival in 456 patients with seudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum 2011; 54: 293-299.
33. Park IJ, Choi GS, Lim KH, et al.: Multidimensional analysis of the learning curve for laparoscopic resection in rectal cancer. J Gastrointest Surg 2009; 13: 275-281.
34. González Bayõn L, Sugarbaker PH, Gonzalez Moreno S,: Initiation of a program in peritoneal surface malignancy. Review. Surg Oncol Clin N Am 2003; 12: 741-753.